MEL can be considered as a valid and safe therapeutic option for the treatment of localized AD in adults and children.
No takes yet. Share an insight, caveat, or question.
Nisticò et al. (2008) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: